If a rate threshold of 0.5% cancers per screen is justifiable, colonoscopies starting at age 25 years for those with MLH1 and MSH2 mutations and at age 30 years for those with MSH6 and PMS2 are appropriate. The gene discussed is PMS2; the disease is cancer.